bupivacaine hydrochloride - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
MARCAIN 0.5% bupivacaine hydrochloride (as monohydrate) 50mg/10mL injection vial
AUST R: 11940
Active ingredients:
bupivacaine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Aspen Pharmacare Australia Pty Ltd

Phone:
1300659646

From
04 Mar 2026
to
13 Apr 2026

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Alternative strengths are available
MARCAIN 0.5%w/v bupivacaine hydrochloride (as monohydrate) 100mg/20 mL injection ampoule
AUST R: 48328
Active ingredients:
bupivacaine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Aspen Pharmacare Australia Pty Ltd

Phone:
1300659646

From
10 Apr 2026
to
26 May 2026

Shortage status:
Anticipated

Availability:
Available

Reason:
Manufacturing

Management action:
Alternative strengths are available.
MARCAIN 0.5% bupivacaine hydrochloride (as monohydrate) 50mg/10mL injection ampoule
AUST R: 11937
Active ingredients:
bupivacaine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Aspen Pharmacare Australia Pty Ltd

Phone:
1300659646

From
23 Dec 2025
to
27 Jan 2026

Shortage status:
Resolved

Availability:
Available

Reason:
Manufacturing
MARCAIN 0.25% EPIDURAL INFUSION bupivacaine hydrochloride (as monohydrate) 250mg/100mL injection bag
AUST R: 11953
Active ingredients:
bupivacaine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Aspen Pharmacare Australia Pty Ltd

Phone:
1300659646

Deletion from market:
01 May 2025

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
An alternative presentation is available